The reference baseline, established.
A framework edition: what reference-grade means, the ten-criteria scoring rubric every quarterly audit applies, and a baseline map of the U.S. research-peptide catalog entering 2026.
- The 10-Criteria Scoring Framework
- What Reference-Grade Means
- The Catalog Entering 2026
- The Catalog Mapped by Class
- Formats & Cold-Chain
- The Year Ahead
- Conclusion & Method
Before a quarterly audit can rank anyone, the category needs a shared definition of reference-grade and a rubric to measure it. This inaugural edition establishes both.
The 10-criteria scoring framework.
Ten weighted criteria, grouped into four tiers. The weights are published so any reader can recompute a supplier's score with their own priorities.
What reference-grade means.
The baseline is uneven by design. Nearly the whole category discloses an HPLC method, but fewer than one in five publish the full release record before purchase. That gap, between disclosure and pre-purchase transparency, is the single dimension the quarterly audits will track most closely. Our Standards & Verification overview and the HPLC purity primer explain how to read each figure in context.
The catalog entering 2026.
Demand is the other half of the baseline. BPC-157 remains the category head term, but the signals worth tracking sit below it, where copper and mitochondrial chemistry are creating search volume that did not exist a year ago.
BPC-157, TB-500, and the GH-axis triad still dominate commercial-intent queries entering 2026. These classes are well documented and well supplied; the baseline question is not whether material exists but how it is verified.
GHK-Cu is the breakout compound entering the year, driven by a skincare crossover. MOTS-c follows with a research audience. These classes are where documentation maturity lags demand, which is exactly the gap the year ahead will test.
The catalog, mapped by class.
The baseline map places each chemistry class by research demand and documentation maturity. Established classes sit upper-right; emerging, in-demand chemistry sits lower-right, which is where the largest documentation gap, and the largest opportunity, lives.
The incretin analogs sit highest on both axes: most studied, best characterized, the reference point for engineered stability. The copper and mitochondrial classes are the ones to watch, high and rising demand against documentation maturity that has not caught up. The class-by-class chemistry lives in Research Overviews.
Formats and cold-chain.
The physical state a compound ships in determines how stable it is and how it has to be handled. Most reference standards ship lyophilized; the baseline tracks the format split and the handling each one demands.
Lyophilized · 70%
Stable, but not indestructible.
Reconstituted · 18%
A shorter, defined window.
Spray · 12%
Pre-reconstituted, handle cold.
Cold-chain
Where standards quietly degrade.
Reconstitution
Done carefully, by the researcher.
Stability
Documented per format.
Held cold and dry, a freeze-dried standard is stable for long periods; the lyophilization cycle shapes how readily it returns to solution. The moment liquid is added the window narrows, which the cold-chain guide covers per format, while the reconstitution calculator handles the concentration math.
The year ahead.
Six directional calls for 2026, drawn from the baseline above. Not predictions, but the structural tensions the framework expects the quarterly audits to surface.
Conclusion and method.
First, the framework is deliberately separable from any one supplier. The ten criteria, their weights, and the six-element release record are published so that a research lab can take them, weight them to its own priorities, and score its own supplier shortlist without us. The audits we publish are one application of the framework; they are not the framework itself.
Second, the baseline is a starting position, not a verdict. Where a class sits on the map entering 2026, or where the category sits on documentation, is the line the quarterly editions will measure movement against. The value of a baseline is entirely in what it lets you compare to later.
The category is not short on chemistry. It is short on a shared, published way to compare what is in the vial.
The Q2 2026 edition is the first measurement against this baseline: a fifty-supplier audit scored on the rubric defined here, with the catalog map revisited as the year develops.
Q2 2026 applies this baseline to the first full audit.
A fifty-supplier audit scored on the rubric defined here, with the catalog map revisited as the year develops. Each subsequent edition revisits the directional calls with a scorecard of what held and what did not.
Read the Q2 2026 ReportCatalog cross-reference
The compounds tracked in this baseline edition map to specific reference standards in the BioFusion catalog. Browse them by class:
Further reading from the BioFusion Reference Library
- Standards & Verification: How Identity and Purity Are Established
- Understanding HPLC Purity: Reading the Number in Context
- USP versus Research-Grade: What the Grade Language Means
- Fmoc versus Boc Synthesis: How the Assembly Route Shapes Purity
- Documentation: Reading the Paperwork That Travels With a Batch
External references
- U.S. FDA, guidance on research-use-only and investigational-use-only in-vitro diagnostic products.
- United States Pharmacopeia, general chapters on chromatographic purity and reference standards.
- Aggregated keyword-volume tooling, U.S. query data, baseline period.
- Public corporate filings and WHOIS registration records for U.S.-facing supplier domains.
- Internal BioFusion Research COA Rubric v1.0 scorecards, available on request.